-
Hi there, Firstly, I would like to express my gratitude for the exceptional work that has gone into developing Cell2location. This computation solution for spatial transcriptomics has greatly impressed me, and I am currently applying it to my own dataset. I'd greatly appreciate some guidance in this process. I'm working with 16 slides sourced from 4 regions of a single organ, obtained from two different donors. For clarification, my samples are labeled as follows:
Where the variable a can be replaced with b, c, and d. My reference dataset consists of 16-paired scRNA-seq data. I've followed the steps outlined in the QUICK START TUTORIAL and have successfully run Cell2location to deconvolve each individual Visium slide based on this reference. I have noticed that the Cell2location model also supports the processing of multiple batches of Visium slides simultaneously. I presume that under this setup, the experiment specific Considering this, I have two questions:
Your insights on this matter would be highly valuable for my ongoing work. Thank you in advance for your time and support. |
Beta Was this translation helpful? Give feedback.
Replies: 2 comments
-
Hi @kuang-da A joint analysis of all sections is useful because it corrects a number of technical effects and leverages more data to estimate and distinguish cell abundance and technology difference effect (greater sensitivity). We recommend using a joint scRNA reference from all sections and joint analysis of all Visium sections - unless there are good reasons to do other wise such as when modelling cancer data from different patients. |
Beta Was this translation helpful? Give feedback.
-
Thank you for the feedback! I am rerunning the analysis with all Visium slides concatenated. |
Beta Was this translation helpful? Give feedback.
Hi @kuang-da
A joint analysis of all sections is useful because it corrects a number of technical effects and leverages more data to estimate and distinguish cell abundance and technology difference effect (greater sensitivity).
We recommend using a joint scRNA reference from all sections and joint analysis of all Visium sections - unless there are good reasons to do other wise such as when modelling cancer data from different patients.